CLINICAL_TRIALS
trial_result
· 2016-02-25
Clinical Trial Update: ESBA1008 Microvolume Study [Phase 2]
Summary
Phase 2 results for the ESBA1008 microvolume study in exudative age-related macular degeneration have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Exudative Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2016-02-25